This Migraine Drug will be a BIG HEADACHE for Lundbeck!!!!

Read today that pandemic will most impact brands that have to be administered in a clinical setting (IV) and are in launch phase. Reason being, with reduced in person clinic visits vs telemedicine, self administered agents ate greatly preferred and HCPs will also be reluctant to switch to new drug, especially if they can not evaluate patient in person.

Uh oh....lol.

 

I am sure panic is setting in over the migraine drug. Nobody In their right mind would go to an infusion Center or a hospital infusion center. Just use one of the 10 second self injectors and be done with it. Alder management must have been in total shock when Lundbeck agreed to pay them $2 billion!

 

Kudos. That's some top notch research, gumshoe. Were your rep senses tingling? Shut the fuck up.

 

Don’t understand, because not a rep. Enjoy your future blue collar job.

 

Don’t understand why non reps trolls message board intended for rep. Weird.

 

It’s because I’m fascinated by what causes someone to choose to become a drug rep. Obviously it’s all about the money, but I enjoy seeing what rationalizations people come up with.

 

Vyepti sales seem to be getting off to a slow start, biggest problem is insurance coverage, there is none

 

I’ve heard that Vyepti is behind in uptake projections. Payers are beginning to hate it. Docs do not want to waste time fighting for it. The rumor is that cluster headache is a consideration... what a clusterfuck

 

Insurance coverage is a Big headache
no coverage, and even PAs getting denied

 

Well, what do you expect from a $2,000,000,000 purchase! Nothing unexpected. It will be a last resort type of medication. Who in their right mind wants to expose themselves to all the people connected with an infusion center, or even make an unnecessary trip to a doctor’s office when you can sit at your breakfast table and give yourself the injection? Doctor’s offices don’t want to do PA’s now more than ever! Maybe you can convince them to do them with a virtual lunch! HA ! HA! HA! What a load of !

 

We are about six months in now, our insurance coverage is absolutely terrible even PAs are getting rejected and what is up with our Vyepti connect program they won’t even help offices do a prior authorization what’s the point of even using them ??
Please tell me how Vyepti connect is beneficial to a doctors office ?
And hospitals And infusion centers are refusing to order in Vyepti because of non existent j code and are worried about not getting reimbursed, also ,even if you get a patient approved through the PA process an the hospital gives the OK to order in one vile, the whole process for the patient to actually get the infusion takes like a month .
What a headache, go thru all that
or try a once a month injection
at your kitchen table, and don’t tell me about efficacy data and quickness of onset of action lol
Also, what is are Reimbursmnt team doing ????

 

Why is reimbursement always such an issue at Lundbeck? Does your clinical data suck, market access suck, or both?

 

Yes to all the above . Vyepti is basically DOA. It’s simply too much trouble to use. Very discouraging. If they bought Alder primarily for this, they really screwed up!

 

The clinical data is fine but it’s not enough to override terrible managed-care coverage And with Covid no patients want to go get IVs anywhere

 

United Health Care coverage for Vyepti is
awsome.
It really stinks when a infusion center agrees to administer Vyepti but they
can’t get it because of our limited supply chain options.

 

Marketing wants us to position Vyepti first or second line but no insurance covers it that way , making us look like a dip shit to the doctors , maybe marketing should talk to the Lundbuck managed-care people.

 

Lundbeck marketing is a oxymoron. Vyepti is done. Simply no need for a late comer like it, especially in this environment. I will never deceive doctors about my drug’s managed care status. This is starting to look like a real dead end.

 

Um, lol, yeah. This company was toast when Idalo failed. Possibly even back when the psych alliances were formed. They realized psych products and European market were a dead end 10 years too late.

 

Add Cigna to the great coverage
we have with Vyepti, tremendous

 

What do you reckon The Rock does when he’s not either being stoopid or lifting weights?